Pyrrolidine-1-carbothioic acid benzylamide, 95.0%, 5g

tert-Butyl 1-oxa-5-azaspiro[2.3]hexane-5-carboxylate, 95.0%, 100mg

Nonenylsuccinic Anhydride (mixture of branched chain isomers)>90.0%(T)500g

Sofosbuvir impurity E, 5mg

(5Z)-5-[[5-(4-Fluoro-2-hydroxyphenyl)-2-furanyl]methylene]-2,4-thiazolidinedione, 98%, 1mg

dibenzo[b,d]furan-4-carboxylic acid, 95.0%, 25g

Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzofuran-2-carboxylate, 98%, 250mg

(R)-6-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine, 97%, 50mg

Ethyl 4-(Trifluoromethyl)-1-benzothiophene-2-carboxylate, 97.0%, 5g

N-(2-bromophenyl)-3-oxobutanamide, 95.0%, 1g

Narrow mouth bottle square clear glass, 500 ml, 32, high form, 10 Piece(s)

2-Hydroxyethyl Methacrylate (stabilized with MEHQ)>95.0%(GC)25g

(3aS,4S,6R,6aR)-6-Methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxylic acid, 97.0%, 5g